Latest News

The FDA has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx alleviates…

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved garadacimab (brand name Andembry) for the prevention of angioedema attacks in individuals aged 12 and…

If approved, the United States would be the world’s first government to adopt such a bold, life-saving step to prevent and decrease smoking-related disease and…

Extra safety information is being added to all montelukast products, Montelukast is a prescription medicine used to prevent and treat chronic asthma in adults and…

New approval by the Medicines and Healthcare products Regulatory Agency (MHRA) of the medicine sotatercept (Winrevair) to treat pulmonary arterial hypertension (PAH). Sotatercept is used, in…

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved tarlatamab (Imdylltra) as a treatment for adult patients with small cell lung cancer (SCLC) that…

The U.S. Food and Drug Administration issued a draft guidance with the Office for Human Research Protections that will offer suggestions for incorporating tissue biopsies into clinical…

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the conditional marketing authorization of givinostat (Duvyzat), a medication used to treat Duchenne muscular dystrophy…

The U.S. Food and Drug Administration authorized Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy in order to steroid-refractory acute graft-versus-host…

The U.S. Food and Drug Administration authorized the use of Crenessity (crinecerfont) in conjunction with glucocorticoids (steroids) to regulate the levels of androgen (a testosterone-like…

A recent study’s findings indicate that Alofisel, a medication used to treat complex anal fistulas in adults with Crohn’s disease, is ineffective. Based on the…

The European Medicines Agency (EMA) has suggested that Welireg (belzutifan) be given a conditional marketing authorization in the EU for people with advanced renal cancer…

European Medicines Agency (EMA) has recommended granting a marketing authorization in the European Union (EU) for Emcitate (tiratricol), an oral medication for individuals with peripheral…

The Holiday season is a busy time for all of us, our friends and our family. Consequently, we could overlook our health in the chaos…

The European Medicines Agency (EMA) has suggested expanding the use of Ofev (nintedanib) to treat progressive fibrosing interstitial lung disorders (ILDs) in children and adolescents…